AlisonUnzeitigBarronMD
General Surgery • San Antonio, TXBreast, Surgical Oncology (Other than Breast)
Breast Surgical Oncology
Dr. Barron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18707 Hardy Oak Blvd Ste 320
San Antonio, TX 78258Phone+1 210-277-6255Fax+1 210-277-6256
Summary
- Dr. Barron attended medical school at the University of Texas Southwestern Medical Center in Dallas, Texas where she obtained her medical doctorate. She then went on to complete a general surgery internship and residency at the University of Texas Southwestern Medical Center and Parkland Hospital where she was also chief resident. Dr. Barron then completed a fellowship in Breast Surgical Oncology at the Mayo Clinic in Rochester, MN.
She is certified by the American Board of Surgery in general surgery and completed a fellowship in breast surgical oncology at a Society of Surgical Oncology accredited program.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Breast Surgical Oncology, 2017 - 2018
University of Texas Southwestern Medical CenterResidency, Surgery, 2012 - 2017
University of Texas Southwestern Medical SchoolClass of 2012
Certifications & Licensure
TX State Medical License 2018 - 2025
MN State Medical License 2017 - 2019
TN State Medical License 2018 - 2019- American Board of Surgery Surgery
Awards, Honors, & Recognition
- George Peters Award American Society of Breast Surgeons, 2018
Publications & Presentations
PubMed
- 9 citationsLocal production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancerJonathan M. Ghergurovich, Jessica D. Lang, Maren K Levin, Natalia Briones, Salvatore Facista
Med. 2021-06-11 - 100 citationsAssociation of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...Alison U. Barron, Tanya L. Hoskin, Courtney N. Day, E. Shelley Hwang, Henry Mark Kuerer
JAMA Surgery. 2018-12-01 - 24 citationsPredicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant ChemotherapyAlison U. Barron, Tanya L. Hoskin, Judy C. Boughey
Annals of Surgical Oncology. 2018-06-28
Journal Articles
- Association of Low Nodal Positivity Rate Among Patients with ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...Henry M Kuerer, Judy C Boughey, Alison U Barron, E Shelley Hwang, JAMA
- Predicting Non-Sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant ChemotherapyJudy C Boughey, Alison U Barron, Annals of Surgical Oncology
Press Mentions
More Than BRCA: The Other Life-Threatening Breast Cancer Gene Mutation to Be Aware OfOctober 4th, 2021
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
External Links
- Texas Oncologyhttps://www.texasoncology.com/doctors/alison-barron
- Texas Breast Specialistshttps://www.texasbreastspecialists.com/physicians/alison-barron
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
